187 filings
15F-12B
PHXM
PHAXIAM Therapeutics S.A.
11 Mar 24
Securities registration termination (foreign)
8:31am
EFFECT
PHXM
PHAXIAM Therapeutics S.A.
6 Mar 24
Notice of effectiveness
12:15am
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:28pm
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:27pm
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:25pm
S-8 POS
wd8s 2u108
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:22pm
S-8 POS
oxr0c3hw 9p232li
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:14pm
POS AM
gxlr q4fyhj4jgyhw
4 Mar 24
Prospectus update (post-effective amendment)
4:09pm
25
yatwy8 o5
1 Mar 24
Voluntary exchange delisting
4:04pm
6-K
py8ircm
21 Feb 24
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
6:05am
6-K
g5jz1n0f tliix
19 Jan 24
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
10:04am
6-K
gozhpn1ip
16 Nov 23
PHAXIAM Provides Business and Financial Update
7:41am
6-K
yjq9d
25 Oct 23
Current report (foreign)
9:21am
6-K
hmb7mh7n8r
11 Oct 23
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
6:53am
6-K
pa9zwrz48t0bi2
5 Oct 23
PHAXIAM Therapeutics and Vetophage Announce
7:32am
6-K
afff4zw2otdf7lmohc
26 Sep 23
I.Certification of the Person Responsible for the Half-year Financial Report
3:01pm
6-K
nth6 vh7f
21 Sep 23
Current report (foreign)
8:42am
6-K
q3877ui0 j53yqh968i
18 Sep 23
PHAXIAM Therapeutics announces the completion of its reverse share split
8:16am
6-K
k7pgy0i5phh4m
15 Sep 23
Current report (foreign)
8:03am
6-K
y8lrvvnaf8j 2g31
7 Sep 23
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
9:33am